LEXICON
No.101 February 6, 2012

Ordinary NHI price revision; price revision based on market prices
通常改定
Re-pricing following market expansion
市場拡大再算定
Special (extraordinary) price cut (reduction)
特例引き下げ
Ad hoc (additional) NHI price cut
追加引き下げ

As a rule, NHI drug prices (薬価) are revised every two years in April based on the results of a market drug price survey conducted in the autumn in the previous year (ordinary NHI price revision; 通常改定). In addition, drugs...

To read the full story

LEXICON

By Yuki Kato

Japan plans to revise its guidelines on the drone delivery of medicines later this month, which would mark the first revision since they were established two years ago. Service providers are closely watching how they will be revised, with calls…

By Eric Persoff

The healthcare supply chain in Japan, as in all major markets, consists of biopharmaceutical manufacturers selling to wholesalers who in turn sell to hospitals, clinics, and pharmacies, where the drugs are finally dispensed to patients. Each party ideally contributes value…

By Yoshinori Sagehashi

The health ministry’s key expert panel on February 15 agreed on the need to consolidate the Japanese generic sector to…

A key Japanese reimbursement policy panel on December 16 approved the government-backed plan for the FY2023 “off-year” drug price revision.…

Authorized generic (AG) strategies taken by innovative drug makers might help soften the impact of generic competition in their businesses but such tactics might also accelerate the application of “G1”/“G2” price cuts for their off-patent brand-name medicines, a Jiho tally…

Japan’s health ministry announced new NHI prices to be applied in April under the FY2022 drug price revision in the official gazette on March 4, with the earlier application of so-called “G1” price cuts to be implemented for the first…